Author

Eduardo Moreo

Universidad de ZaragozaORCID 0000-0002-0182-201XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cell type annotation· 2 Research Focus:host-pathogen & immune response· 2 Assay:scRNA-seq· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

Ana Belén GómeziD· 2 shared Carlos Martı́niD· 2 shared Miguel Araujo‐VocesiD· 2 shared Nacho AguilóiD· 2 shared Santiago UrangaiD· 2 shared Aaron James FordeiD· 1 shared Ana Jiménez· 1 shared Carlos del FresnoiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Ana Belén GómezORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Comparative analysis of BCG vaccination routes in mice reveals preferential reprogramming of pulmonary macrophages upon mucosal administration

Aaron James Forde, Mara Esposito, Emanuela Kerschbamer, David Schreiner, Eduardo Moreo, Nikos Pantouloufos, Tiphaine Camarasa, J. Lima, Habiba Soliman, Maike Erber, Claire E. Depew, Wadschma Naderi, Carolyn G. King

This study compares BCG vaccination routes in mice, showing that mucosal delivery reprograms interstitial macrophages and enhances protection against TB.

Mucosal Immunology · Jul 26, 2026Peer-reviewedImmunology

NK cells mediate preventive efficacy of intravenous BCG against lung metastasis in mice

Claudia Guerrero, Marta Casal, Cristina Alierta, Eduardo Moreo, Miguel Araujo‐Voces, Santiago Uranga, Ana Belén Gómez, Carlos Martı́n, Nacho Aguiló

This study shows that intravenous BCG reduces lung metastases from bladder cancer in mice by activating NK cells, but is ineffective against established tumors due to immune evasion mechanisms.

Cancer Gene Therapy · Aug 2, 2025Peer-reviewedImmunology

BCG-induced reprogramming of monocyte/macrophage populations enhances lung antitumor immunity in mice

Eduardo Moreo, Miguel Araujo‐Voces, Luna Minute, Laura Bravo-Robles, Ana Jiménez, Santiago Uranga, Ana Belén Gómez, Carlos Martı́n, Carlos del Fresno, Nacho Aguiló

This study shows that IV BCG reprograms monocyte/macrophage populations in mice, shifting them to pro-inflammatory phenotypes that enhance antitumor immunity by boosting NK and T cell responses.

bioRxiv · Jul 25, 2025 · PreprintImmunology